Assembly Biosciences, Inc. is a public biotechnology company advancing a new class of oral biologic therapeutics for leveraging the therapeutic potential of the gut microbiome and novel approaches to discovering and developing therapeutics for the treatment of hepatitis B virus (HBV) infection.

NEWS

See all news